Stockreport

Alzamend Neuro Announces Reverse Stock Split

Alzamend Neuro, Inc.  (ALZN) 
PDF ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel p [Read more]